Mackay Shields LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Mackay Shields LLC's PFE Position: Q2 2022 in Review
Mackay Shields LLC sold out of Pfizer (PFE) in Q2 2022, closing a stake of 806,614 shares — an estimated $41.8M sold.
Mackay Shields LLC first reported a position in PFE in Q1 2018 and held it in 17 quarters. The position peaked at $74.3M in Q3 2018. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.
- Mackay Shields LLC reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
- Mackay Shields LLC sold 806,614 Pfizer shares in Q2 2022, an estimated $41.8M.
- Mackay Shields LLC first reported a position in Pfizer in Q1 2018 and held it in 17 quarters.
- Mackay Shields LLC's Pfizer position peaked at $74.3M in Q3 2018.
- 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.
Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.